Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ORALVAC COMPACT BÄUME
- Development stage
- Unknown
- Lead developer
- Allergy Therapeutics
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Sublingual
01
Overview
ORALVAC COMPACT BÄUME is a sublingual immunotherapy (SLIT) product containing standardized aqueous allergen extracts from tree pollens, specifically birch, alder, and hazel. It is used for the treatment of IgE-mediated allergic diseases such as allergic rhinitis, conjunctivitis, and asthma triggered by these tree pollens. The therapy works by gradually exposing the immune system to small amounts of allergens to induce tolerance and reduce allergic symptoms over time. The up-dosing phase can be completed rapidly in a clinical setting or more gradually at home, followed by a maintenance phase with daily dosing. Clinical studies have shown that it is well tolerated and effective in reducing symptoms and medication use during pollen seasons[2][5][6]. It is suitable for adults and children from 2 years of age[5][6]. Developed by Allergy Therapeutics, this product is marketed primarily in Europe.
- Brand names
- ORALVAC COMPACT BÄUMEOralvac Compact
- Other names
- OralvacSublingual allergy vaccine (trees)Oralvac Compact Trees
02
Targets
MHC II (Major histocompatibility complex class II receptor)
Beyond the preview
Go deeper on ORALVAC COMPACT BÄUME.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ORALVAC COMPACT BÄUME.